Disease | kidney cancer |
Phenotype | C1261473|sarcoma |
Sentences | 1 |
PubMedID- 20945947 | Anti-tumor responses were demonstrated in nine different refractory and/or relapsed cancers, including evaluable patients with sarcoma (5 of 5; 100%), kidney cancer (7 of 7; 100%), lymphoma (1 of 1; 100%), and non-small cell lung cancer (2 of 3; 67%). |
Page: 1